ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Bio-Techne Corp

Bio-Techne Corp (1TECH)

0,00
0,00
(0,00%)
Geschlossen 04 Juli 5:30PM

Bio-Techne Corp (1TECH) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
-
( - )
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
-
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
4.298.231 €
Ausgegebene Aktien
155.828.504
Dividendenrendite (LTM)
0,32 (0,72%)
Kurs-Gewinn-Verhältnis
102,2
Gewinn pro Aktie (EPS)
0,69
Erlöse (LTM)
1,21B
Nettogewinn (LTM)
109,56M

Über Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biol... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Minneapolis, United States
Gegründet
1976
Bio-Techne Corp is listed in the sector of the Italienische Börse with ticker 1TECH. The last closing price for Bio-Techne was -. Over the last year, Bio-Techne shares have traded in a share price range of 0,00 € to 0,00 €.

Bio-Techne currently has 155.828.504 shares in issue. Bio-Techne has a price to earnings ratio (PE ratio) of 102.20.

1TECH Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

1TECH - Frequently Asked Questions (FAQ)

What is the current Bio-Techne Corp share price?
The current share price of Bio-Techne Corp is 0,00 €
How many Bio-Techne Corp shares are in issue?
Bio-Techne Corp has 155.828.504 shares in issue
What is the 1 year trading range for Bio-Techne Corp share price?
Bio-Techne Corp has traded in the range of 0,00 € to 0,00 € during the past year
What is the PE ratio of Bio-Techne Corp?
The price to earnings ratio of Bio-Techne Corp is 102,2
What is the cash to sales ratio of Bio-Techne Corp?
The cash to sales ratio of Bio-Techne Corp is 9,14
What is the registered address of Bio-Techne Corp?
The registered address for Bio-Techne Corp is 614 McKinley Place N.E., Minneapolis, Minnesota, 55413
What is the Bio-Techne Corp website address?
The website address for Bio-Techne Corp is www.bio-techne.com

1TECH Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen